Gastroparesis following bone marrow transplantation

被引:26
作者
Eagle, DA
Gian, V
Lauwers, GY
Manivel, JC
Moreb, JS
Mastin, S
Wingard, JR
机构
[1] Univ Florida, Coll Med, Div Hematol, Gainesville, FL 32610 USA
[2] Sarah Cannon Canc Ctr, Nashville, TN USA
[3] Univ Minnesota, Coll Med, Minneapolis, MN USA
关键词
gastroparesis; hematopoietic cell transplant; gastric emptying; nausea and vomiting;
D O I
10.1038/sj.bmt.1703084
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Patients often develop nausea, vomiting and bloating after bone marrow transplantation (BMT). These symptoms may interfere with nutrition and the ability to take oral medications. Gastroparesis is a recognized cause of these symptoms in non-transplant patients but less is known about patients who undergo BMT. Between January 1996 and March 1997, a total of 151 patients underwent BMT. Eighteen patients (12%) developed persistent symptoms suggestive of gastroparesis (persistent nausea, vomiting or bloating). Scintigraphic gastric emptying studies were performed to assess for gastroparesis. Prokinetic agents were administered at the time of study. The records on these patients were compared with those of all other patients undergoing BMT during the same time period without these symptoms. Nine patients who demonstrated delayed gastric emptying were further evaluated with esophagastroduodenoscopy and biopsy. Biopsy samples were reviewed for evidence of graft-versus-host disease (GVHD). Fourteen of 18 patients demonstrated delayed gastric emptying and most responded to prokinetic agents given at the time of study. Age, conditioning regimen, cytomegalovirus antigenemia and acute GVHD did not appear to be associated with the development of gastroparesis. Allogeneic BMT recipients were at higher risk than autologous BMT patients (26% vs 0%, P < 0.0001). Of allogeneic BMT recipients, there was a nonsignificant trend of patients receiving tacrolimus to be less likely to experience gastroparesis than those receiving cyclosporine (27 % vs 48 %, P = 0.08). For the nine patients undergoing upper endoscopy, GVHD on gastric biopsy was an uncommon finding and was mild when present. Gastroparesis appears to be a common cause of nausea, vomiting and bloating following allogeneic BMT. This may occur less often with tacrolimus than cyclosporine because of the former agent's prokinetic properties. Patients usually respond to prokinetic drugs at the time of scintigraphy. GVHD and CMV infection do not appear to be major contributing factors.
引用
收藏
页码:59 / 62
页数:4
相关论文
共 12 条
[1]   UPPER GASTROINTESTINAL DYSMOTILITY IN HEART-LUNG TRANSPLANT RECIPIENTS [J].
AU, J ;
HAWKINS, T ;
VENABLES, C ;
MORRITT, G ;
SCOTT, CD ;
GASCOIGNE, AD ;
CORRIS, PA ;
HILTON, CJ ;
DARK, JH .
ANNALS OF THORACIC SURGERY, 1993, 55 (01) :94-97
[2]   GASTROPARESIS AFTER LUNG TRANSPLANTATION - POTENTIAL ROLE IN POSTOPERATIVE RESPIRATORY COMPLICATIONS [J].
BERKOWITZ, N ;
SCHULMAN, LL ;
MCGREGOR, C ;
MARKOWITZ, D .
CHEST, 1995, 108 (06) :1602-1607
[3]   Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantation [J].
Brand, RE ;
DiBaise, JK ;
Quigley, EMM ;
Gobar, LS ;
Harmon, KS ;
Lynch, JC ;
Bierman, PJ ;
Bishop, MR ;
Tarantolo, SR .
LANCET, 1998, 352 (9145) :1985-1985
[4]  
DOMSTAD PA, 1980, J NUCL MED, V21, P1098
[5]  
FAHEY FH, 1989, J NUCL MED, V30, P233
[6]  
Hecht JR, 1997, CANCER-AM CANCER SOC, V79, P1698, DOI 10.1002/(SICI)1097-0142(19970501)79:9<1698::AID-CNCR9>3.0.CO
[7]  
2-8
[8]  
JAEHOON J, 1990, MAYO CLIN P, V65, P636
[9]   SOLID-PHASE GASTRIC-EMPTYING IN PATIENTS WITH BARRETTS-ESOPHAGUS [J].
JOHNSON, DA ;
WINTERS, C ;
DRANE, WE ;
CATTAU, EL ;
KARVELIS, KC ;
SILVERMAN, ED ;
SPURLING, TJ ;
CHOBANIAN, SJ ;
DUBOIS, A .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (11) :1217-1220
[10]   Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine [J].
Maes, BD ;
Vanwalleghem, J ;
Kuypers, D ;
Ghoos, Y ;
Rutgeerts, PJ ;
Vanrenterghem, YFC .
TRANSPLANTATION, 1999, 68 (10) :1482-1485